Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT.

Redjoul, Rabah; Le Bouter, Anne; Parinet, Vincent; Fourati, Slim; Maury, Sébastien

Redjoul, Rabah; Le Bouter, Anne; Parinet, Vincent; Fourati, Slim; Maury, Sébastien.

Redjoul R; Haematology Department, Assistance Publique, Hôpitaux de Paris, Henri Mondor Hospital, Créteil 94000, France.
Le Bouter A; Virology Department, Assistance Publique, Hôpitaux de Paris, Henri Mondor Hospital, Créteil 94000, France.
Parinet V; Haematology Department, Assistance Publique, Hôpitaux de Paris, Henri Mondor Hospital, Créteil 94000, France.
Fourati S; Virology Department, Assistance Publique, Hôpitaux de Paris, Henri Mondor Hospital, Créteil 94000, France; INSERM U955, Université Paris Est Créteil Val de Marne, Créteil, France.
Maury S; Haematology Department, Assistance Publique, Hôpitaux de Paris, Henri Mondor Hospital, Créteil 94000, France; INSERM U955, Université Paris Est Créteil Val de Marne, Créteil, France. Electronic address: sebastien.maury@aphp.fr.

Lancet Haematol ; 8(10): e681-e683, 2021 Oct.

Article in English | MEDLINE | ID: covidwho-1454686

Subject(s)

COVID-19 Vaccines/therapeutic use; COVID-19/prevention & control; Hematopoietic Stem Cell Transplantation; Aged; Antibody Formation; BNT162 Vaccine; COVID-19/immunology; COVID-19 Vaccines/administration & dosage; COVID-19 Vaccines/immunology; Female; Humans; Immunity, Humoral; Male; Middle Aged; SARS-CoV-2/immunology; Transplantation, Homologous

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Lancet Haematol Year: 2021 Document Type: Article Affiliation country: S2352-3026(21)00274-x

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google